Table 1.
Demographic and clinical characteristics in 13 patients with COVID-19 and 92 with influenza pneumonia
| Parameters | Virus | p* | |||
|---|---|---|---|---|---|
| COVID-19 | Influenza | ||||
| Total | Influenza A | Influenza B | |||
| Age | 49.54 ± 17.419 | 53.91 ± 20.311 | 57.29 ± 19.977 | 37.88 ± 13.236 | 0.371 |
| Sex | 1 | ||||
| Male | 7 (53.8%) | 51 (55.4%) | 43 (56.6%) | 8 (50%) | |
| Female | 6 (46.2%) | 41 (44.6%) | 33 (43.4%) | 8 (50%) | |
| Signs and symptoms | |||||
| Fever | 12 (92.3%) | 73 (79.3%) | 59 (77.6%) | 14 (87.5%) | 0.454 |
| Cough | 4 (30.8%) | 76 (82.6%) | 61 (80.3%) | 15 (93.8%) | 0.000 |
| Myalgia | 2 (15.4%) | 19 (20.7%) | 16 (21.1%) | 3 (18.8%) | 1 |
| Laboratory assay results | |||||
| White blood cell count (× 109/l) | 5.46 ± 1.377 | 6.76 ± 2.667 | 6.84 ± 2.629 | 6.33 ± 2.893 | 0.076 |
| Neutrophil count (× 109/l) | 3.58 ± 1.139 | 5.13 ± 2.498 | 5.19 ± 2.495 | 4.86 ± 2.580 | 0.061 |
| Lymphocyte count (× 109/l) | 1.29 ± 0.565 | 1.06 ± 0.529 | 1.10 ± 0.557 | 0.89 ± 0.333 | 0.515 |
| Monocyte count (× 109/l) | 0.40 ± 0.219 | 0.50 ± 0.261 | 0.49 ± 0.257 | 0.54 ± 0.285 | 0.548 |
| Time duration (days)# | 1.54 ± 0.946 | 4.42 ± 3.557 | 4.41 ± 3.636 | 4.44 ± 3.265 | 0.019 |
*p < 0.05 indicates a significant difference
#Time duration: The time duration from onset of symptoms to the CT examination